Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.
Olivieri A, Santini G, Patti C, Chisesi T, De Souza C, Rubagotti A, Aversa S, Billio A, Porcellini A, Candela M, Centurioni R, Congiu AM, Brunori M, Nati S, Spriano M, Vimercati R, Marino G, Contu A, Tedeschi L, Majolino I, Crugnola M, Sertoli MR; NHLCSG. Olivieri A, et al. Among authors: marino g. Ann Oncol. 2005 Dec;16(12):1941-8. doi: 10.1093/annonc/mdi399. Epub 2005 Sep 12. Ann Oncol. 2005. PMID: 16157621 Free article. Clinical Trial.
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V. Santini G, et al. Among authors: marino g. Haematologica. 2000 Feb;85(2):160-6. Haematologica. 2000. PMID: 10681723 Clinical Trial.
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C. Santini G, et al. Among authors: marino g. Leuk Lymphoma. 2004 Jun;45(6):1141-7. doi: 10.1080/10428190310001623874. Leuk Lymphoma. 2004. PMID: 15359993
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.
Santini G, De Souza C, Congiu AM, Nati S, Marino G, Soracco M, Sertoli MR, Rubagotti A, Spriano M, Vassallo F, Rossi E, Vimercati R, Piaggio G, Figari O, Benvenuto F, Abate M, Truini M, Ravetti JL, Ribizzi I, Damasio E. Santini G, et al. Among authors: marino g. Leuk Lymphoma. 1999 Apr;33(3-4):321-30. doi: 10.3109/10428199909058432. Leuk Lymphoma. 1999. PMID: 10221512 Clinical Trial.
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study.
Capelli D, Santini G, De Souza C, Poloni A, Marino G, Montanari M, Lucesole M, Brunori M, Massidda D, Offidani M, Leoni P, Olivieri A. Capelli D, et al. Among authors: marino g. Br J Haematol. 2000 Aug;110(2):300-7. doi: 10.1046/j.1365-2141.2000.02149.x. Br J Haematol. 2000. PMID: 10971385 Free article. Clinical Trial.
1,009 results